Phase 1 Dose-Escalation Study of the Rapid-Clearance Radioligand [(177)Lu]Lu-P17-087 in Metastatic Castration-Resistant Prostate Cancer: Dosimetry, Safety, and Preliminary Efficacy.
- DOI
- 10.2967/jnumed.126.272406
- Published
- 2026 Sep 24
- Container
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2967/jnumed.126.272406,
title = {Phase 1 Dose-Escalation Study of the Rapid-Clearance Radioligand [(177)Lu]Lu-P17-087 in Metastatic Castration-Resistant Prostate Cancer: Dosimetry, Safety, and Preliminary Efficacy.},
author = {Zhao R and Li M and Lv J and Zhang J and Zhong H and Fu Y and Liu J and Gu D and Zeng G and Kung HF and Zhu L and Huang J and Wang X},
year = {2026},
journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
doi = {10.2967/jnumed.126.272406},
url = {https://doi.org/10.2967/jnumed.126.272406}
}RIS
TY - JOUR TI - Phase 1 Dose-Escalation Study of the Rapid-Clearance Radioligand [(177)Lu]Lu-P17-087 in Metastatic Castration-Resistant Prostate Cancer: Dosimetry, Safety, and Preliminary Efficacy. AU - Zhao R AU - Li M AU - Lv J AU - Zhang J AU - Zhong H AU - Fu Y AU - Liu J AU - Gu D AU - Zeng G AU - Kung HF AU - Zhu L AU - Huang J AU - Wang X PY - 2026 JO - Journal of nuclear medicine : official publication, Society of Nuclear Medicine DO - 10.2967/jnumed.126.272406 UR - https://doi.org/10.2967/jnumed.126.272406 ER -
APA
R, Z., M, L., J, L., J, Z., H, Z., Y, F., J, L., D, G., G, Z., HF, K., L, Z., J, H., & X, W. (2026). Phase 1 Dose-Escalation Study of the Rapid-Clearance Radioligand [(177)Lu]Lu-P17-087 in Metastatic Castration-Resistant Prostate Cancer: Dosimetry, Safety, and Preliminary Efficacy.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.126.272406
Source records
- pubmed · retrieved 2026-09-25T10:34:59.073Z